captvivekjain
Long

Divi's Labs is a sure-shot pill to profit

NSE:DIVISLAB   DIVI'S LABORATORIE
158 2 6
The scrip is at Rs             774 with a price and volume break-out today.
It is resting on 20D EMA and with NIFTY's assistance in coming weeks, may gallop to close the huge fall experienced earlier from Rs             1100 levels mainly due to US FDA inspection and recommendations.
The company has completed the recommendations satisfactorily and is waiting for market fancy.
Technically and fundamentally, it is underpriced. Book Value is a healthy Rs             195, PE=18, a debt-free balance sheet , growing turnover and profits, it should return to its previous glory             pretty soon.
Thanks for your views, I am adding it right away to my portfolio !
Reply
Thanks for your wonderful analysis!

Agree with your views - I have a lot of Divi's Lab shares in my portfolio - I also believe it is fundamentally very sound and shown consistent profit and growth in all segments over the years and presents a very good opportunity to buy currently.
+1 Reply
English (IN)
English
English (UK)
Deutsch
Français
Español
Italiano
Polski
Türkçe
Русский
Português
Bahasa Indonesia
Bahasa Melayu
ภาษาไทย
Tiếng Việt
日本語
한국어
简体中文
繁體中文
Home Stock Screener Forex Signal Finder Cryptocurrency Signal Finder Economic Calendar How It Works Chart Features House Rules Moderators Website & Broker Solutions Widgets Stock Charting Library Feature Request Blog & News FAQ Help & Wiki Twitter
Profile Profile Settings Account and Billing My Support Tickets Contact Support Ideas Published Followers Following Private Messages Chat Sign Out